CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
-
-
The US Dept of Veterans Affairs conducted deep-dive study into effects of COVID-19 on Veterans
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
-
Atossa Therapeutics announced second COVID-19 therapeutic development program, AT-301 nasal spray
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
-
Heat Biologics announced collaboration with Waisman Biomanufacturing to manufacture COVID-19 vaccine
On May 27, 2020, Heat Biologics announced a collaboration with Waisman Biomanufacturing to establish a partnership for the…
-
Quest Diagnostics launched COVID-19 workforce testing services to help organizations in fostering safer workplaces
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
-
Analysis of COVID-19 genomes revealed large numbers of introductions to the UK in March, 2020
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
-
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
-
Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossa’s proprietary COVID-19 drug…
-
Llama antibody engineered to block Coronavirus
On May 19, 2020, the National Institutes of Health (NIH) reported that researchers from the University of Texas,…
-
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
-
Oragenics and Aragen Bioscience enter agreement to accelerate development of TerraCoV2, a SARS-CoV-2 (COVID 19) vaccine candidate
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
-
Roche highly accurate antibody test for COVID-19 went live at more than 20 initial lab sites in the US
On May 19, 2020, Roche announced its Elecsys Anti-SARS-CoV-2 antibody test is live at more than 20 commercial…
-
Hologic granted FDA Emergency Use Authorization for its second molecular test for COVID-19
On May 15, 2020, Hologic announced it had received Emergency Use Authorization (EUA) from the U.S. Food and Drug…
-
Harvard-led initiative awarded over $16.5 million to support 62 COVID-19 research projects
On May 13, 2020, the Massachusetts Consortium on Pathogen Readiness (MassCPR), a multi-institutional initiative convened by Harvard Medical…
-
National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
-
Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel Coronavirus
On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…
-
Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus
On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…
-
Abbott received FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity i System
On May 11, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA)…
-
SARS-CoV-2 targets many cell types, analysis of single-cell data suggests
On May 11, 2020, HHMI announced that scientists had identified places the new coronavirus, called SARS-CoV-2, may invade…
-
Thermo Fisher Scientific to double its capacity of viral vector manufacturing
On May 11, 2020, Thermo Fisher Scientific announced it is expanding capacity for viral vector development and manufacturing…
-
Biotechnology | COVID-19 | Diagnostics | Environmental | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Rice University COVID-19 research fund backed six new initiatives
On May 8, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had funded…
-
RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
-
OPKO Health’s BioReference Laboratories launched COVID-19 antibody screening for New York City residents
On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available…
-
Air Force Genetics Laboratory, DHA collaborate to further sequence SARS-CoV-2 code
On May 11, 2020, the Air Force Genetics Center of Excellence at Keesler Air Force Base in Biloxi,…
-
Risk factors for COVID-19 death revealed in world’s largest analysis of patient records to date
On May 7, 2020, academics at the University of Oxford and the London School of Hygiene & Tropical…
-
Sanger scientist received Chan Zuckerberg Initiative support for COVID-19 study
On May 7, 2020, the Wellcome Sanger Institute announced that Roser Vento-Tormo, a Group Leader was one of…
-
Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
-
PharmaCyte Biotech received medical devices registration and submited pre-EUA application to the FDA for COVID-19 diagnostic kit
On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the U.S. Food and…
-
Meridian Bioscience partnered with QuantuMDx on COVID-19 assay
On May 6, 2020, Meridian Bioscience announced a collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for…
-
Innovation Pharma announced the next phase of Brilacidin Coronavirus testing begun
On May 5, 2020, Innovation Pharma reported it had executed executed a Material Transfer Agreement (MTA) with a…
